Back
Day Range
$34.57
$36.77
52-Week Range
$23.23
$50.79
Volume
526,314
50D / 200D Avg
$43.32
/
$38.94
Prev Close
$35.44
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 17.5 | 0.4 |
| P/B | 3.7 | 2.9 |
| ROE % | 23.7 | 3.8 |
| Net Margin % | 8.1 | 3.9 |
| Rev Growth 5Y % | 29.6 | 10.0 |
| D/E | 3.1 | 0.2 |
Key Takeaways
Revenue grew 29.58% annually over 5 years — strong growth
ROE of 23.70% indicates high profitability
Debt/Equity of 3.12 — high leverage
Generating 327.58M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 5.96%
Cash machine — converts 521.05% of earnings into free cash flow
Growth
Revenue Growth (5Y)
29.58%
Revenue (1Y)23.62%
Earnings (1Y)-9.13%
FCF Growth (3Y)9.28%
Quality
Return on Equity
23.70%
ROIC11.30%
Net Margin8.05%
Op. Margin23.97%
Safety
Debt / Equity
3.12
Current Ratio1.57
Interest Coverage2.27
Valuation
P/E Ratio
17.54
P/B Ratio3.66
EV/EBITDA9.58
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 23.62% | Revenue Growth (3Y) | 17.36% |
| Earnings Growth (1Y) | -9.13% | Earnings Growth (3Y) | 14.26% |
| Revenue Growth (5Y) | 29.58% | Earnings Growth (5Y) | -3.17% |
| Profitability | |||
| Revenue (TTM) | 780.57M | Net Income (TTM) | 62.87M |
| ROE | 23.70% | ROA | 3.79% |
| Gross Margin | 59.35% | Operating Margin | 23.97% |
| Net Margin | 8.05% | Free Cash Flow (TTM) | 327.58M |
| ROIC | 11.30% | FCF Growth (3Y) | 9.28% |
| Safety | |||
| Debt / Equity | 3.12 | Current Ratio | 1.57 |
| Interest Coverage | 2.27 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 17.54 | P/B Ratio | 3.66 |
| P/S Ratio | 1.41 | PEG Ratio | -3.12 |
| EV/EBITDA | 9.58 | Dividend Yield | 0.00% |
| Market Cap | 1.10B | Enterprise Value | 1.79B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780.57M | 631.45M | 566.77M | 463.93M | 276.87M |
| Net Income | 62.87M | 69.19M | 48.16M | -25.00M | 71.52M |
| EPS (Diluted) | 1.73 | 1.86 | 1.29 | -0.74 | 1.86 |
| Gross Profit | 463.26M | 377.34M | 326.17M | 209.49M | 150.62M |
| Operating Income | 187.08M | 169.90M | 166.96M | 33.32M | 17.63M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.66B | 1.66B | 1.14B | 1.17B | 692.08M |
| Total Liabilities | 1.36B | 1.43B | 947.88M | 979.29M | 489.15M |
| Shareholders' Equity | 301.68M | 228.84M | 195.43M | 194.84M | 202.93M |
| Total Debt | 940.56M | 859.30M | 674.28M | 709.18M | 258.75M |
| Cash & Equivalents | 251.10M | 70.57M | 238.95M | 173.69M | 186.43M |
| Current Assets | 691.41M | 482.26M | 537.60M | 419.99M | 315.54M |
| Current Liabilities | 440.03M | 509.51M | 457.92M | 433.73M | 279.57M |